Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Assistance Publique - Hôpitaux de Paris | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to reduce the length of stay after liver surgery by taking account of objective quantitative clinical variables, subjective qualitative clinical variables and non clinical variables.
a new dimension of the activity expected of physicians is to improve the safety of care on the one hand and the control of health care costs on the other.
key measures to help them are the publication of national recommendations, assessment of actual practices and the incentive to activity.
Internationalwide recent and concordant data suggest that
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| operated patients | this cohort includes patients who underwent a liver surgery whatever the pathology and whatever the surgical procedure |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| liver surgery | Procedure | this intervention type includes hepatectomies; wedge; segmentectomies etc... |
|
| Measure | Description | Time Frame |
|---|---|---|
| overall postoperative length of stay | the overall postoperative length of stay is defined as the hospitalization between the surgery and patient's discharge. This period includes the readmission for at least 24 hours in case of outcomes related to the surgery. | during the 3 months after the surgery |
| Measure | Description | Time Frame |
|---|---|---|
| peroperative outcomes | the peroperative outcomes are collected during the surgery and correspond to any event occured during the surgical intervention | during the surgical procedure |
| postoperative outcomes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
the population corresponds to patients operated in one of the thirteen hospitals.
These hospitals are distributed on the french territory to ensure that the recruitment is representative of the general population
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Olivier FARGES, MD, phD | Beaujon University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Amiens North Hospital | Amiens | France | ||||
| Bordeaux Hospital |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 28991876 | Derived | Cauchy F, Farges O, Vibert E, Boleslawski E, Pruvot FR, Regimbeau JM, Mabrut JY, Scatton O, Adham M, Laurent C, Gregoire E, Delpero JR, Bachellier P, Soubrane O. Sensitizing Surgeons to Their Outcome Has No Measurable Short-term Benefit. Ann Surg. 2017 Nov;266(5):884-889. doi: 10.1097/SLA.0000000000002403. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006528 | Carcinoma, Hepatocellular |
| D018285 | Klatskin Tumor |
| D002277 | Carcinoma |
| D018281 | Cholangiocarcinoma |
| D009362 | Neoplasm Metastasis |
| ID | Term |
|---|---|
| D000230 | Adenocarcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
the postoperative outcomes correspond to any event occured after the surgical intervention. These outcomes include fistulae; bleeding...
| after the surgery until postoperative month 3 |
| construct of pronostic models | the construct of pronostic models include variables that affect the length of stay; morbidity and mortality | after the postoperative month 3 |
| evaluation of PMSI indicators | this evaluation includes the analysis of PMSI indicators; their validity and the influence of centres on hepatectomies results | after the postoperative month 3 |
| Bordeaux |
| France |
| Beaujon University Hospital | Clichy | France |
| Lille Regional Hospital | Lille | France |
| Lyon Hospital | Lyon | France |
| Marseille Hospital | Marseille | France |
| Paoli calmette institute | Marseille | France |
| Saint Antoine Hospital | Paris | France |
| Strasbourg hospital | Strasbourg | France |
| Gustave Roussy institute | Villejuif | France |
| Paul Brousse Hospital | Villejuif | France |
| D008113 | Liver Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D004066 | Digestive System Diseases |
| D008107 | Liver Diseases |
| D009385 | Neoplastic Processes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |